Efinaconazole Liniment

艾氟康唑搽剂

Report date: 2024/12/13 16:50:26

Base Information

Drug NameEfinaconazole Liniment
Drug Alias NameTY1801JTY-1801J
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLanosterol 14α-demethylase inhibitors
TargetsLanosterol 14α-demethylase
Therapy Area/IndicationsOnychomycosisMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesKaken Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Taipu Huya Pharmaceutical Technology Co LtdKaken Pharmaceutical Co Ltd Shizuoka FactoryKaken Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOnychomycosisMycoses
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A